Introduction
Magnetic Resonance Imaging (MRI) is a medical imaging technique that has been in clinical use since the 1980's, and has advanced significantly in the last decade. MRI scans are usually performed at magnetic field strengths of 1.5 to 3.0 Tesla. Such a magnetic field is at least 25,000 times stronger than that of the earth and is required to align and modify the behaviour of unevenly charged protons in the patient's body. Brief radio frequency pulses with specific properties are applied, which change the axis of rotation (precession) in the protons. The protons rapidly resume their original precession angle and emit a small signal, which is used to compute images. Importantly, the behaviour of resuming their previous state is strongly dependent on the molecular environment; in other words: different tissue composition creates different image contrasts (14) (15) (16) The main advantages of MRI techniques include their completely non-invasive nature, lack of any harmful radiation or radioactivity, and the lack of need for Iodine-based contrast agents. It is considered to be free of any harm to patients, but -since metal is affected in a magnetic field -it may not be performed if the patient carries certain magnetic material such as specific electronic devices or some metallic implants. The most commonly performed MRI scans are of the head, brain, spine, large joints and abdomen (15) . Cardiac applications of MRI have been applied since the late 1980's and have evolved into a robust, clinically valid application due to recent advances in both hardware and software. CMR provides a variety of valuable diagnostic information including anatomy and function of the heart, flow of blood, and perfusion and viability of the myocardium. Its most unique advantage is the ability to visualize tissue characteristics selectively based on molecular environments, adding a new and valuable piece of information to medical testing 426 Contrast-enhanced cardiac magnetic resonance imaging (CMR) allows for a non-invasive assessment of the tissue composition using contrast-free (T2, e.g. STIR) and contrastenhanced techniques (early and late Gadolinium enhancement). Together with a functional assessment, it can be used to determine the acuity of e.g. inflammatory diseases and provide a non-invasive follow-up tool.
CMR techniques used
Functional imaging with high-resolution sequences such as SSFP cines allow to assess the whole left and right ventricles and calculate volumes, ejection fraction and mass. Myocardial wall stress can be calculated from these. Assessment of valvular function is needed and may require additional flow studies for the calculation of regurgitation fraction of aor t i c a n d m i t r a l v a l v e . A s s e s s m e n t o f t h e pericardium can be done on the functional images, too. T2-weighted images with fat suppression allow assessing myocardial water content, thus allowing to assess the stage of disease. To provide an "internal standard", skeletal muscle is used as control; an SI-ratio of more than 2.0 is considered abnormal. T1-weighted images allow to demonstrate acute inflammatory changes including increased extracellular volume and membrane integrity. As in T2-weighted imaging a skeletal muscle is used as "internal standard"; an enhancement -ratio (myocardial enhancement / muscle enhancement) of more than 4.0 is considered abnormal. The body-coil is used to obtain homogenous SI through the images, short axis or axial images are selected to optimize image quality. Newer sequences may improve image quality and allow for the use of multi-element coils. Late Gadolinium enhancement allows to non-invasively diagnose irreversible damage in the myocardium (e.g. fibrosis, infarcts). Due to the specific location in ischemic damages (starts at the subendocardial layer), it is easy to distinguish non-ischemic damages (as in myocarditis) from ischemic problems. Combining T2-information, early and late enhancement, CMR is able to safely assess the acuity and reversibility of the disease process in non-ischemic Cardiomyopathies and inflammatory processes (16).
Left ventricular non-compaction 2.1 Introduction
Left ventricular non-compaction (LVNC) is a distinct cardiomyopathy resulting from arrest of fetal development of the heart (1). This leads to altered myocardial architecture that is seen as a two layered myocardium with a thin, compacted epicardial layer and a thick, non-compacted endocardial region. The non-compacted myocardial region is comprised of prominent trabeculations and deep intertrabecular recesses that directly communicate with the left ventricular cavity (2, 3) .The condition may present without any associated cardiac malformation and is then labelled isolated left ventricular non compaction (LVNC). Non compacted myocardium is also seen in conjunction with other cardiac abnormalities including cyanotic congenital heart disease, Ebstein's anomaly and other cardiomyopathies. Clinical p r e s e n t a t i o n i n L V N C i s s e e n w i t h c o n g e s t i ve heart failure, ventricular arrhythmia and systemic thromboembolism. The condition is listed as an unclassified cardiomyopathy in the WHO and European Society of Cardiology classification of cardiomyopathies (4, 5) and as a primary genetic cardiomyopathy in the American Heart Association classification (6) . 
Pathophysiology
Early intrauterine myocardial perfusion is through direct diffusion of nutrients from the left ventricular (LV) cavity to the myocardium. The presence of deep trabecular recesses filled with blood facilitates this process. Development of coronary circulation in the second trimester provides direct blood supply to the myocardium with consequent compaction of extensive intrauterine trabeculations of the myocardial wall. Failure in this process results in a non-compacted myocardium (1). The exact mechanism for this is not known.
Inheritance
Both sporadic and familial forms are described. In the latter an autosomal dominant or Xlinked inheritance with genetic heterogeneity is reported. Mutations in MYH7 encoding βmyosin heavy chain is seen in patients with Ebstein's anomaly and LVNC (7) . In X-linked inheritance mutation of G4.5 TAZ gene with abnormality of tafazzin is reported (8, 9) . This can be seen with or without Barth syndrome.
Prevalence
The presence of significant non compaction is estimated at 1:2.000 in the general population (10) . The condition is, however, more prevalent in heart failure patients. More frequent use of cardiac imaging in clinical practice has increased recognition of this condition.
Clinical presentation
This is variable from asymptomatic individuals to those with severe disease presenting with heart failure, ventricular arrhythmia and systemic thromboembolism (9, (11) (12) (13) . Non cardiac features may include facial dysmorphism and neuromuscular disorders.
Diagnostic criteria
Trabeculation in the LV wall is seen even in healthy volunteers. To separate benign LV trabeculation from pathological LVNC following diagnostic criteria is proposed.
-Echo: ratio of non-compacted to compacted myocardium in end-systole of > 2:1 (14) -Cardiac MRI: ratio of non-compacted to compacted myocardium in end-diastole of > 2.3:1 (15)
Cardiac MRI in the diagnosis of LVNC
Cardiovascular imaging is central to the diagnosis of left ventricular non compaction. Compared to echocardiography better resolution of cardiac MRI makes it a preferred imaging modality particularly in those with limited echo windows. Additionally, noncompacted segment may be confined to the LV apex where echo has inherent imaging problems. Cardiac MRI is also reliable in distinguishing LVNC from other causes of LV apical deformity including apical variant of hypertrophic cardiomyopathy, endomyocardial fibrosis and apical thrombus.
Cardiac MRI imaging protocol
LV morphology and function is evaluated with cine images using a steady-state free precession (SSFP) technique. Images are usually displayed in three to six long axes and in contiguous short axis projections.
After baseline imaging post Gadolinium delayed enhancement (LGE) is performed to assess myocardial fibrosis.
Myocardial morphology on cardiac MRI
Besides pathological LVNC myocardial trabeculation is also seen in normal healthy individuals as well as in patients with hypertrophic and dilated cardiomyopathies. In LVNC distribution of non-compacted myocardium can be accurately assessed by MRI. There is involvement of the LV apex along with more frequent non compaction of the mid and apical segments of inferior and lateral wall. Non-compaction of the right ventricular wall is seen in some of these individuals. However, it is the severity of non-compaction rather than the distribution that distinguishes pathological LVNC from other disorders (15) . A ratio of noncompacted to compacted myocardium of > 2.3 in diastole has as a sensitivity of 86% with a very high specificity of 99% and positive and negative predictive values of 75% and 99% respectively.
In contrast to echocardiography where systolic frame images are used to measure the relationship of non-compacted to compacted myocardium, diastolic frame images are used in MRI. This is possible because of improved spatial resolution of MRI. In systole, thickening of compacted myocardium may account for the altered relationship of compacted and noncompacted myocardium and this may explain the lower ratio of non-compacted to compacted myocardium of > 2:1 used in echocardiography (15) .
Others have suggested that a trabeculated LV mass of > 20% of the total LV mass separates LVNC from other causes of LV trabeculation both benign and that seen in dilated and hypertrophic cardiomyopathy with a sensitivity and specificity of > 90%(16).
Myocardial kinetics and function
Cine short-axis images are used for calculation of ejection fraction (EF) using Simpson's method by tracing end diastolic and end systolic volumes in all imaging planes.
The spectrum of myocardial function may range from normal to severe systolic dysfunction. Quantitative assessment of left ventricular function by cardiac MRI is the current reference standard and can be compared longitudinally. However, in patients with LVNC interobserver and intraobserver reproducibility may be affected, depending on whether the inner contour (interface between the LV cavity and non-compacted myocardium) or outer contour (interface between the compacted and non-compacted myocardium) are used to calculate LV volumes. Latter may have the effect of increasing left ventricular end-diastolic volume and falsely overestimating volumetric EF (17) . Therefore, additional qualitative information of LV function from review of myocardial kinetics on cine images is suggested. 
Tissue characterization-late gadolinium enhancement

Clinical management
This is largely supportive with standard heart failure therapy. Heart transplantation remains an option in patients with advanced disease. Ventricular arrhythmia is not directly related to severity of LV dysfunction and a prophylactic ICD is recommended. Anticoagulation to prevent thromboembolic complications is recommended, particularly in patients with severe contractile dysfunction. Family members of affected individual should be screened and counseled.
Summary
Left ventricular non-compaction is a rare cardiomyopathy arising from developmental arrest of the left ventricular myocardium. It has distinct morphometric appearance with a two layer myocardium-a compacted and a non-compacted zone. Sporadic and familial forms are described. The triad of heart failure, arrhythmia and systemic thromboembolism are feared complications. In milder forms the patient may be completely asymptomatic. Increased awareness of this disorder and improvement in cardiovascular imaging has contributed to greater recognition of this condition. Cardiac MRI with its improved spatial resolution can conclusively establish the diagnosis and the unique property of LGE on cardiac MRI can identify severe forms of this disorder which may have both therapeutic and prognostic implications.
Stress-induced or "Tako-Tsubo" cardiomyopathy
Introduction
This cardiomyopathy is a transient and reversible cardiomyopathy that was first reported in Japan by Dote, et al., in 1991 (1) . Clinical presentation may be indistinguishable from acute coronary syndrome, invariably necessitating coronary angiography for exclusion of obstructive coronary artery disease. Prevalence is in 1-2% of patients undergoing coronary angiography for acute coronary syndrome. Complimentary imaging modalities including echocardiography and cardiac MRI are helpful in diagnosis and in monitoring clinical recovery. Absence of delayed hyperenhancement on cardiac MRI is particularly important in differentiating this condition from ischemic and other types of non-ischemic cardiomyopathy and acute myocarditis (2) . Based on morphologic features of the left ventricle, presumed causative role of stress and catecholamine excess and transient nature of the contractile dysfunction, other nomenclature used to describe this cardiomyopathy include ampulla cardiomyopathy, stress cardiomyopathy or catecholamine cardiotoxicity and transient left ventricular apical ballooning syndrome.
Pathophysiology
Distinct pattern of contractile abnormality is noted in the left ventricle. In the typical case the LV apex is dyskinetic and expanded and may be associated with hyperdynamic contractility of the basal LV segments. The shape of left ventricle in systole resembles a Japanese octopus trap (Takotusbo), which has a narrow neck and a wide base (1). The condition is associated with markedly elevated circulating catecholamine, which is assumed to be central in the pathophysiology of this condition though exact mechanism at the cellular level is not fully understood. In a report by Wittstein, et al., two to three times higher plasma catecholamine concentrations were found in 13 patients with transient LV apical ballooning syndrome compared with 7 controls hospitalized for acute MI with Killip class III heart failure (3) . Other proposed mechanisms include neurogenic stunned myocardium, coronary vasospasm, microvasculature dysfunction and altered cellular metabolism (4, (8) (9) (10) (11) . Preponderance of females afflicted by this condition is unclear. Estrogen deficiency in the post-menopausal state may play a role. Of particular interest, in other conditions with elevated catecholamine levels like subarachnoid hemorrhage, segmental wall motion abnormality is also predominantly seen in women (12) . A reverse pattern of contractile abnormality with apical sparing has also been reported (13).
Clinical features
The presentation is typically following intense emotional or physical stress. The condition is predominantly seen in post-menopausal female with more than 80% of patients being female and more than 90% above the age of 50 years. Presentation may be clinically indistinguishable from ACS including ST segment elevation on ECG and rise in cardiac biomarkers. Chest pain and mild dyspnea are most common features encountered in more than 70% of patients. More significant heart failure and some degree of LVOT tract obstruction from hyperdynamic contraction of basal LV segments may be encountered in 15-20% of patients. Complications including cardiogenic shock may complicate the clinical course in up to 5% of patients. This may be secondary to either severe LV systolic dysfunction or obstruction of LVOT or both. Systemic thromboembolism from apical LV thrombus is reported. Ventricular arrhythmia is seen in 1-2% of patients (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) .
Although presentation is typically encountered in the setting of profound emotional or physical stress, this characteristic trigger can be absent in up to a third of patients (14) . Right ventricular involvement in takotsubo is seen in 25-30% of patients and is associated with a more complicated clinical course (15) . It is encountered in patients with more severe LV involvement (16) . However, isolated right ventricular takotsubo has been reported (17).
Diagnosis
History of intense emotional or physical stress and a typical pattern of left ventricular contractile dysfunction on cardiac imaging are suggestive of the diagnosis. Invariably, however, coronary angiography is required in the acute setting to exclude obstructive coronary artery disease. Both echocardiography and cardiac MRI provide information on the distinct morphologic and contractile dysfunction of takotsubo cardiomyopathy. However, cardiac MRI is instrumental in conclusively distinguishing takotsubo cardiomyopathy from other conditions.
Cardiac MRI in the diagnosis of Takotsubo cardiomyopathy 3.5.1 Assessment of myocardial morphology and contractility
Imaging sequence includes Standard TrueFISP (fast imaging with steady-state precession) cine images acquisition in 3 long-axis slices and 11 to 15 short-axis slices, 7 mm in thickness with a 3-mm interslice gap, achieving full ventricular coverage. Apical ballooning with or without mid myocardial contractile dysfunction and with basal sparing can be easily appreciated. In addition hyperdynamic contraction of basal segments with LVOT obstruction can be identified. The above-described pattern of contractile dysfunction in takotsubo cardiomyopathy does not fit a coronary artery distribution and is helpful in differentiating this condition from acute coronary syndrome. Left ventricular apical thrombus, which can complicate the clinical course, can be diagnosed using the long axis cine projections and LGE images.
Right ventricular involvement is seen in some patients. Because of the difficulty in assessing RV morphology and function by echocardiography, cardiac MRI is a preferred modality for identification of right ventricular involvement (15) (16) (17) and in quantification of RV dysfunction. However, cautious interpretation of RV dysfunction by MRI is advised in view of some degree of projection dependent contractile dysfunction seen even in normal subjects (18) (19) . Sequential cardiac imaging study will show normalization of contractile dysfunction within a few days to weeks. 
Tissue characterization -Myocardial edema on t2-weighted images
Myocardial edema following myocardial injury, ischemic or non-ischemic, can be detected using T2-weighted short tau inversion recovery (T2-STIR) images obtained in basal, mid, and apical short-axis, vertical long-axis, 3-chamber, and horizontal long-axis planes (20) . Elevated T2-signal consistent with myocardial edema is seen in patients with takotsubo cardiomyopathy. T2 signal is highest in myocardium with the most impaired function and resolves over time (21) (22) . Myocardial edema on T2-STIR sequence is also a hallmark of ischemic myocardium prior to irreversible myocardial injury (23) . In contrast to ischemic myocardium, myocardial edema in patients with takotsubo cardiomyopathy may represent catecholamine-induced myocardial stunning due to microvascular dysfunction (2). 
Tissue characterization -Late gadolinium enhancement (LGE) on T1-weighted Images
Gadolinium concentrates in region of damaged myocardium and appears bright on T1weighted images (24) . Cine images using a segmented gradient-echo sequence (6-mm slice thickness) is obtained in multiple short-axis views every 10 mm covering the whole left ventricle (LV). Ten to 15 min after injection of a Gadolinium-based contrast agent, images are acquired in the same orientation as the cine images using a segmented inversionrecovery gradient-echo pulse sequence. Abnormal myocardium is usually bright on T1weighted images.
LGE is absent in patients with takotsubo cardiomyopathy (2, 3, 5, 25) . This indicates viable myocardium and is particularly useful in distinguishing it from myocardial infarction, other types of non-ischemic cardiomyopathy and myocarditis.
In a prospective study using CMR conducted by Eitel, et al., 6.100 patients presenting with ACS underwent coronary angiography and left ventriculography. In 59 patients with normal coronary angiography and typical contractile pattern of takotsubo cardiomyopathy, cardiac MRI was performed. Using strict criteria of absence of any late Gadolinium enhancement, takotsubo cardiomyopathy was diagnosed in 38. In the remaining 21 patients, based on the pattern of delayed hyperenhancement, a diagnosis of ischemic heart disease was made in 13 and of myocarditis in 8 patients (2) . However, in a study of 15 patients with takotsubo cardiomyopathy, low intensity, patchy, mid-myocardial LGE was seen in 5 out of 15 patients. Increase in extracellular collagen was reported to be a plausible mechanism for this finding (26).
Coronary magnetic resonance angiography (MRA)
Coronary MRA though quite helpful in delineating the course of proximal coronary arteries (27) , is not feasible for assessment of obstructive coronary artery disease and hence cannot be substituted for invasive or CT angiography (28).
Management
Treatment is supportive. ß-blockers are the mainstay in blunting catecholamine cardiotoxicity. This should be used cautiously to avoid worsening of heart failure. In patients with cardiogenic shock inotropic and IABP support may be required. However, the possibility of exacerbating LVOT obstruction with these measures requires careful monitoring and appropriate adjustment of therapy including discontinuation of inotropes and IABP support (29) . ACE-I are beneficial and warfarin is recommended till left ventricular recovery is complete. In addition to these therapeutic measures, emotional or physical precipitating factors should be addressed. Prognosis is usually very good with complete or near complete recovery of LV contractile dysfunction. For prevention of rare recurrent episodes of takotsubo even after removal of initial trigger, indefinite neurohormonal modulation with ß-blockers and ACE-I merits consideration (30).
Summary
Takotsubo cardiomyopathy presents with clinical features that can be indistinguishable from acute coronary syndrome. However, distinct myocardial contractile dysfunction on echocardiography or cardiac MRI, absence of obstructive CAD on invasive angiography and exposure to an emotional or physical stressor is helpful in initially distinguishing it from ACS. Furthermore, cardiac MRI with normal first-pass contrast enhanced rest myocardial perfusion, reversible myocardial edema in regions of contractile dysfunction and absence of late gadolinium enhancement is strongly indicative of the diagnosis of takotsubo cardiomyopathy. Resolution of contractile dysfunction, days to weeks after initial presentation, is confirmatory of the diagnosis.
